Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. RIVULET MEDIA INC. (RIVU) Message Board

Of course I am with you on the majority of your po

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 5066
Posted On: 08/01/2013 6:12:30 AM
Avatar
Posted By: patientgal
Re: stacksonstacks #1931

Of course I am with you on the majority of your post--I find the PR to be very good news. Considering that HemaXellerate is the first of several treatments for various diseases--diseases that command medical treatments in the multi-billion of dollars per year--once the FDA gives its stamp of approval, because of the nature of the treatment and that OVERALL the HemXellerate approach is found to be safe, the other treatments derived from HemXellerate will be a cake-walk.


Further, how anyone could look at that PR and conclude this means the treatment is a no-go is beyond me. Or, how anyone could read it and conclude that it will be months before they complete the Q&A. Though few really understand how the FDA works most if not all should understand by now with the information that has been provided that this is a very time consuming process. As I have noted before, before e-filing with the IRS, it could take months before people saw their tax refunds in their mailboxes. Even with e-file it can take weeks or sometimes months. We are talking about being granted approval to conduct medical trials on human patients by one of the most scrutinized agencies in the world. They are not going to rush anything for anyone.


That being said, the company filed their answers to the FDA's first set of questions on 20 May. One month later on 21 June, they received a further questions of which Dr. Koos had this to say:



"we received a second set of FDA comments stating several of their questions were adequately addressed, however additional data needs to be submitted,"



The PR then states:



Based on experiments that FDA requested, the company generated new data further demonstrating efficacy of HemaXellerate I™ in animal models. This may be seen in the figure attached.



It does not say they are currently generating the data. It says the company generated. Which pretty much states that what the FDA required the FDA now has. Now they are in hurry up and wait mode. But how long do they have left to wait? Months? Weeks? Days? No more? Fact is, no one knows. Given by the amount of time between Q & A up to this point, I am guessing not long at all.


The only thing that was left to further clarify was efficacy of the treatment. Not safety. And efficacy has been proved by the already generated data.


Surely no one expects a PR where the CEO of a biotech states "welp, I told the FDA to get a move on it so we will have our answers in a couple of days."? Again, they are exactly where they should be. And for all we know, that seal of approval could have arrived yesterday after the PR.


Those that bailed based on a PR that they clearly did not understand deserve to crying at their screens when they see the price move up after the announcement of trials. And to sound like a curmudgeon myself, I wish I could be a fly on the wall, laughing hysterically at their misery. Especially those who have been pounding on their chest in between insults and attempts to humiliate!


And that brings me to my last point and where I do not agree with your insistence that the boards have little effect on the pps. Within minutes of the PR being released and pasted on iHub, the volume went from next-to-nothing comparatively speaking to (less than 10 million) to a tick over 70 million within a span of, what, 2 hours. The PR had hardly any time to be indexed. You would have literally been refreshing Google or Marketwire every 60 seconds or so to get it when it was since the PR had just been published. The influence of these boards on a penny stock is incredible.


I am glad you were able to increase your position. I have no doubt you will be so very happy you did!


Off to see the wizard...I shall return.







(0)
(0)




RIVULET MEDIA INC. (RIVU) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us